Journal Information
Editorial
Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention
Spencer Goble, Angelo Z. Mattos, Manuel Mendizabal, Jose D. Debes
Ann Hepatol. 2023;28:101149
Full text access
Opinions
Intravenous albumin in cirrhosis: Updated clinical uses and novel perspectives
Roberta Gagliardi, Nicola Zeni, Salvatore Piano
Ann Hepatol. 2023;28:101150
Full text access
Concise reviews
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
Full text access
Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao
Ann Hepatol. 2023;28:101137
Full text access
Original articles
A novel nomogram for predicting microvascular invasion in hepatocellular carcinoma
Yuan Chang, Tianyu Guo, Bo Zhu, Yefu Liu
Ann Hepatol. 2023;28:101136
Full text access
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Raffaele Brustia, Mohamed Bouattour, Manon Allaire, Marie Lequoy, Clémence Hollande, Hélène Regnault, Lorraine Blaise, Nathalie Ganne-Carrié, ... the “Paris Liver Cancer Group”
Ann Hepatol. 2023;28:101141
Full text access
Analysis of the impact of fatty acid metabolism on immunotherapy for hepatocellular carcinoma
Jinhuan Wang, Xinmin Jin
Ann Hepatol. 2023;28:101148
Full text access
Develop and validate a novel online AIHI-nomogram to predict severe liver inflammation in patients with autoimmune hepatitis
Zhiyi Zhang, Jian Wang, Huali Wang, Yiguang Li, Li Zhu, Yun Chen, Jiacheng Liu, Yilin Liu, ... Chao Wu
Ann Hepatol. 2023;28:101134
Full text access
Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1α signaling pathway
Jing Yang, Suxin Li, Shengyan Liu, Yuehui Zhang, Dongqi Shen, Peiju Wang, Xiaowei Dang
Ann Hepatol. 2023;28:101135
Full text access
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
Lucy Gracen, Withma Muthukumara, Melanie Aikebuse, Anthony Russell, James O'Beirne, Katharine M. Irvine, Suzanne Williams, Gaurav Puri, ... Elizabeth E. Powell
Ann Hepatol. 2023;28:101142
Full text access
Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis
Haotang Ren, Hai Li, Guohong Deng, Xianbo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhongji Meng, ... Yu Shi
Ann Hepatol. 2023;28:101147
Full text access
Clinical practice guidelines
Consensus document on acute-on-chronic liver failure (ACLF) established by the Mexican Association of Hepatology
Aldo Torre, Laura Esthela Cisneros-Garza, Mauricio Castillo-Barradas, Nalu Navarro-Alvarez, Ricardo Sandoval-Salas, María Sarai González-Huezo, José Luís Pérez-Hernández, Osvely Méndez-Guerrero, ... Francisco Alfonso Solís-Galindo
Ann Hepatol. 2023;28:101140
Full text access
Letters to the editor
Prognostic value of lactate/albumin ratio in patients with acute-on-chronic liver failure
Yalcin Golcuk, Burcu Kaymak Golcuk
Ann Hepatol. 2023;28:101161
Full text access
Brushing your teeth may be good for your liver: Linking oral health to non-alcoholic fatty liver disease
Yusuf Yilmaz
Ann Hepatol. 2023;28:101159
Full text access